<´╗┐script src="/scripts/jquery.magnific-popup.min.js"><´╗┐/script>
  • Director, Ocuoplastics, Reconstructive Surgery and Oncology, UH Case Medical Center
  • Professor, Ophthalmology, CWRU School of Medicine
  • Professor, Pathology, CWRU School of Medicine


Board Certifications

American Board of Ophthalmology - Ophthalmology

Education & Training


1975, University of Michigan

Medical / Professional School(s)

1979, University of Michigan Medical School


1981, General Surgery - St Joseph Mercy Ann Arbor


1989, Ophthalmology - DMC Sinai Grace Hospital


1986, Ophthalmalic Pathology - Armed Forces Institute of Pathology
1990, Ocular Oncology - UCSF Medical Center at Parnassus


Cancer of the Eye, Comprehensive Ophthalmology, Eye Disease, Eye Pathology, Eye Reconstructive Surgery, Melanoma, Ocular Oncology, Ocular Pathology, Ophthalmic Reconstructive Surgery, Orbital Disease

Office Locations

UH Case Medical Center
Department of Ophthalmology
11100 Euclid Ave
Cleveland, OH 44106
Get Directions

UH Landerbrook Health Center
5850 Landerbrook Dr
UH Eye Institute, Ste 306
Mayfield Heights, OH 44124
Get Directions

UH Westlake Health Center
950 Clague Rd
UH Eye Institute, Bldg B, Ste 102
Westlake, OH 44145
Get Directions

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

For calendar year 2013, David Bardenstein, MD did not disclose any Outside Relationships with Industry.